Suven Life Sciences Limited has informed the Exchange regarding 'ESOP Grant'.
SUVEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Suven Life Sciences has granted 345,000 stock options to eligible employees under its Employee Stock Option Scheme 2020 (SLSL ESOP 2020), approved by the Nomination & Remuneration Committee on May 13, 2025. Each option carries the right to one equity share of face value ₹1, at an exercise price of ₹55 per option. The options will vest in three tranches over three years — 40% in May 2026, 30% in May 2027, and 30% in May 2028 — with a two-year exercise window after each vesting. The scheme is compliant with SEBI (SBEB) Regulations, 2021. No options have been exercised or lapsed so far under this grant.
This is a routine ESOP grant with a mild dilutive effect over time as options vest and get exercised. It aligns employee incentives with shareholder interests and is not expected to materially impact the stock price in the short term.